We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » More Drugmakers Pursuing Non-competitive Research Partnerships, Deloitte Says
More Drugmakers Pursuing Non-competitive Research Partnerships, Deloitte Says
Drugmakers are increasingly using joint ventures and research consortia to accelerate early stages of drug development and share the burden of cost, according to Deloitte.